The lipopolysaccharide (LPS) of nontypeable H. influenzae (NTHi) can be substituted at various positions by Nacetylneuraminic acid (Neu5Ac). LPS sialylation plays an important role in pathogenesis. The only LPS sialyltransferase characterised biochemically to date in H. influenzae is Lic3A, an α-2,3-sialyltransferase responsible for the addition of Neu5Ac to a lactose acceptor (1) . Here we describe a second sialyltransferase, Lic3B, which is a close homologue of Lic3A and present in 60% of NTHi isolates tested. A recombinant form of Lic3B was expressed in E. coli and purified by affinity chromatography. We used synthetic fluorescent acceptors with a terminal lactose or sialyllactose to show that Lic3B has both α -2,3-and α-2,8-sialyltransferase activities. Structural analysis of LPS from lic3B mutant strains of NTHi confirmed only monosialylated species were detectable, whereas disialylated species were detected upon inactivation of l i c 3 A . Furthermore, introduction of lic3B into a lic3B-deficient strain background resulted in a significant increase in sialylation in the recipient strain. Mass spectrometric analysis of LPS indicated that glycoforms containing two Neu5Ac residues were evident that were not present in the LPS of the parent strain. These findings characterise the activity of a second sialyltransferase in H. influenzae, responsible for the addition of di-sialic acid to the LPS. Modification of the LPS by disialylation conferred increased resistance of the organism to the killing effects of normal human serum, as compared to monosialylated or non-sialylated species, indicating that this modification has biological significance.
Sialylation of lipopolysaccharide (LPS)
is a widely conserved structural modification among mucosal pathogens, with a reported role in virulence in a number of organisms. In Haemophilus influenzae, LPS sialylation has been demonstrated to be important in resistance to the killing effects of normal human serum. A significant decrease in bacterial survival in human serum was observed in sialylationdeficient mutants, in which the CMP-Neu5Ac synthetase gene (siaB) had been disrupted, compared to the wild-type organisms (2) . Furthermore, the role of sialylation as a critical virulence factor in the pathogenesis of experimental otitis media has been demonstrated, Neu5Ac-deficient mutants of nontypeable H. influenzae (NTHi) were profoundly attenuated in a chinchilla model of infection (3) . Related to this, it has been proposed that LPS sialylation may be implicated in the formation of biofilms (4) (5) (6) . These studies provide evidence that Neu5Ac-containing LPS promotes bacterial persistence in vivo, potentially indicating a multi-faceted role for Neu5Ac in bacterial colonisation and disease.
Virtually all NTHi strains tested include Neu5Ac in their LPS (2, 7) , but the patterns of sialylation and the repertoire of putative sialyltransferases differ between strains. Two common sialylated species have been identified to date in H. influenzae LPS, sialylated lactose and sialylated lacto-N-neotetrose (2, 8, 9) . Lic3A, t h e o n l y biochemically characterised 2 sialyltransferase in H. influenzae, is responsible for the addition of Neu5Ac in a α-2,3-linkage to a lactose acceptor on the LPS of H. influenzae (1) . Just within the 5' end of the lic3A open reading frame are tandem repeats of the tetranucleotide 5'CAAT (10) and hence, the encoded sialyltransferase is subject to phase variation. In some strain backgrounds, terminal N-acetyllactosamine expressed as part of a lacto-N-neotetrose-like structure is also sialylated. Likely candidate enzymes to sialylate such structures in H. influenzae are encoded by the sialyltransferase gene homologues lsgB and siaA (originally termed orfY) (6, 9, 11, 12) . In a minority of NTHi strains, disialic acid residues have been detected in a small proportion of LPS glycoforms (2) , indicating a potential role for another sialyltransferase in these strains able to use Neu5Ac as an acceptor. Alternatively, a sialyltransferase enzyme capable of performing both reactions may exist in some H. influenzae strains as has been reported in Campylobacter jejuni (13) where a bifunctional sialyltransferase has been described. The findings from the current study provide the first evidence that a bifunctional sialyltransferase exists in H. influenzae.
Experimental procedures
Bacterial strains and culture conditionsTwenty-six NTHi isolates used in this study, designated 162, 176, 285, 375, 432, 477, 486, 667, 723, 981, 1003, 1008, 1124, 1158, 1159, 1180, 1181, 1200, 1207, 1209, 1231, 1232, 1233, 1247, 1268, 1292 , were obtained from the Finnish Otitis Media Study Group. Isolates were obtained from the middle ear of patients with otitis media and selected as being representative of the genetic diversity of H. influenzae after ribotyping analysis (14) . Thirty-two typeable H. influenzae isolates were also used in this study, representing serotypes a to f (15) . H. influenzae was grown at 37°C in brain heart infusion (BHI) broth supplemented with hemin (10 µg/ml) and NAD (2 µg/ml). BHI plates were prepared with 1% agar and supplemented with 10% Levinthals base (16) and when appropriate kanamycin (10 µg/ml), tetracycline (4 µg/ml) or Neu5Ac (25 µ g/ml). E. coli strain DH5α was used to propagate plasmids and was grown at 37°C in LB broth (17) supplemented when appropriate with ampicillin (100 µg/ml), kanamycin (50 µg/ml) or tetracycline (12 µg/ml (8) . Briefly, LPS was O-deacylated by treatment with anhydrous hydrazine at 37 o C for 1 h. Samples were analysed in the negative ion mode by using a Prince CE system (Prince Technologies, The Netherlands) coupled to an API 3000 mass spectrometer (Applied Biosystems/Sciex, Concord, Canada) via a microIonspray interface. The separations were obtained on ca. 90 cm length bare fused-silica capillary using 30 mM morpholine in deionized water, pH 9.0, containing 5 % methanol. A voltage of 30 kV was applied at the injection and a sheath solution (isopropanol-methanol, 2:1) was delivered at a flow rate of 1.0 µL/min. Expression and purification of recombinant Lic3A and Lic3B -The lic3A and lic3B genes were amplified by PCR from NTHi isolate 375 chromosomal DNA using Pwo polymerase. The following primers; H I -0 6 ( 5 ' CTTAGGAGGTCATATGTCAAAGTCTGTCA TTATTGCAGGTAATGG 3', NdeI site in i t a l i c s ) a n d H I -0 7 ( 5 ' CCTAGGTCGACCTAATCCCATTTTCTTGA TTTTAAGGCGTG 3', SalI site in italics) were used to amplify the lic3A gene. The following primers were used to amplify lic3B; HI-15 (5' CTTAGGAGGTCATATGTCAAAGCCTGTCA TTATTGCAGGTAATGG 3', NdeI site in i t a l i c s ) a n d H I -1 6 ( 5 ' CCTAGGTCGACTTATTTGCGTAGTCTCAT TTTCTTTGC 3', SalI site in italics). The PCR products were digested with NdeI and SalI and cloned in pCWori+(-lacZ) containing the sequence encoding the E. coli maltose-binding protein (MalE) (without the leader peptide) and the thrombin cleavage site. E. coli AD202 strains containing either construct HST-06 (lic3B from NTHi isolate 375 in pCWori+) or HST-08 (lic3A from NTHi isolate 375 in pCWori+) were grown in 2 x YT medium containing 150 µg/ml ampicillin and 2 g/l glucose. The cultures were incubated at 37 o C until A 600 = 0.35, induced with 1 mM IPTG, and then incubated overnight at 25 o C. The cells were broken using an Avestin C5 Emulsiflex cell disruptor (Avestin, Ottawa) and the MalE-Lic3A and MalE-Lic3B fusions were purified by affinity chromatography on amylose resin following the manufacturer's instructions (New England Biolabs, Beverly, MA). Enzymatic assay conditions -The sialyltransferase assays were performed at 37 O C for 5 min. The α-2,3-sialyltransferase activity was assayed using CMP-Neu5Ac as donor and Galβ-1,4-Glc-FCHASE as acceptor, in 50 mM Hepes pH 7.5 containing also 10 mM MnCl 2 . The α-2,8-sialyltransferase activity was assayed using CMP-Neu5Ac as donor and Neu5Acα-2-3-Galβ-1,4-Glc-FCHASE as acceptor, in 50 mM Hepes pH7.5 containing also 10 mM MnCl 2 . The transialidase activity was assayed at 37 o C for 20 min using Neu5Acα-2-3-Galβ-1,4-Glc-FCHASE as donor and CMP as acceptor, in 50 mM Mes pH 6.0 containing also 10 mM EDTA. All the reactions were stopped by the addition of acetonitrile (25% final concentration). The purified enzymes were diluted in order to observe between 3 and 10% conversion of the substrate into product during the incubation times indicated above. The samples were analysed by capillary electrophoresis as by guest on October 5, 2017 http://www.jbc.org/ Downloaded from described previously (Wakarchuk, W. W. and Cunningham, A. M. (2003) Methods Mol. Biol. 213, 263-274) . Quantitation of the reactions was performed by integration of the capillary electrophoresis trace peaks using the MDQ 32 Karat software (Beckman, CA). The sialyltransferase and transialidase activities are expressed in milliunits (nanomoles of product per minute) per mg of purified fusion proteins. Serum bactericidal assay -Bacteria cultured to mid-log phase in BHI broth, supplemented with Neu5Ac (100 µg/ml), were resuspended in PBS. 10 6 organisms were taken and incubated in 10% pooled normal human serum for 30 mins. Following incubation, surviving bacteria were enumerated by dilution and culture on plates.
RESULTS

A novel locus containing a 5'CAAT tetranucleotide repeat tract is homologous to
lic3A -A comprehensive survey of tetranucleotide repeats in a set of 25 NTH i isolates by Southern analysis identified a novel lic3A homologue (20) . Several NTHi isolates exhibited two restriction fragments that hybridised correspondingly to both an internal lic3A probe and a (5'CAAT) 5 oligonucleotide probe. The novel lic3A hybridising restriction fragment from NTHi isolate 375, i.e. that which showed no equivalent banding pattern in identical hybridisation analyses with the genome sequenced strain, Rd, was cloned to give plasmid pAA2. Following DNA sequencing of the cloned insert an open reading frame encoding a protein of 333 amino acids with high homology to Lic3A was identified. This Lic3A homologue was flanked upstream by HI0865, a GTPbinding protein with homology to bipA (21) , and downstream by HI0864, a glutamine synthetase gene, glnA. GlnA is immediately adjacent to the hmg locus (HI0866 to HI0874), which contains multiple genes responsible for the synthesis and incorporation of the lacto-N-neotetrose-like structure, expressed on the LPS of a range of capsular and NTHi strains (12) . This second copy of lic3A has been designated lic3B.
Primers HI0864 and HI0865 (Supplementary data), designed against the DNA sequences flanking lic3B, were used to amplify by PCR portions of HI0864 and HI0865 that are contiguous in the Rd genome sequence and any DNA located between them. 11 of 25 NTH i isolates tested gave an amplification product of 1.6 kb, indicating a gene organisation like that of strain Rd, however, in 14 of the isolates a product of 2.6 kb was amplified indicating an insertion of DNA in this region of the chromosome. Upon Southern analysis, all of the larger PCR amplification products hybridised to a lic3A probe, indicating that the inserted DNA is conserved between strains (data not shown). A survey of the presence of l i c 3 B in 32 H . influenzae capsular strains, representing serotypes a to f, by PCR amplification, indicated that lic3B was present in a lower proportion (31%) of capsular H. influenzae strains than observed with NTHi (60%). The lic3B gene was found to be absent from the serotype c and d strains tested, and was present in 86% of serotype a strains, 50% of serotype f strains, 25% of serotype e strains and 17% of serotype b strains tested (data not shown).
The l i c 3 A gene is phase variably expressed due to a 5'CAAT tetranucleotide repeat tract located within the reading frame (22) . Lic3B also contains a 5'CAAT repeat tract located at the same position relative to the downstream open reading frame. The DNA sequence of the tetranucleotide repeat tracts within lic3A and lic3B in the 25 NTHi isolates was obtained and the number of repeated motifs was found to vary from 14 to 41 in lic3A and from 12 to 28 in lic3B. For both genes, two of the three possible reading frames are predicted to allow for translation of full-length gene products from alternative initiation codons (ATG1 and ATG2), immediately upstream of the repeats. The amino acid sequences of Lic3A (GenBank accession number DQ447744) and Lic3B (GenBank accession number DQ444277) from NTHi isolate 375 share 93% similarity and 91% identity (Supplementary data). Disruption of lic3B eliminates disialylation of LPS -To investigate the function of lic3B, the cloned gene from NTH i isolate 375 was inactivated by insertion of a kanamycin resistance cassette then used to transform NTHi isolates 375 and 1003. To confirm that only lic3B had been specifically targeted and that lic3A had not been altered, PCR amplification using lic3A-and lic3B-specific primers along with Southern hybridisation analysis was used to confirm the integrity of the transformants (data not shown). NTHi isolate 1003 was chosen as a second strain background in which to study the function of Lic3B since the detailed structure of the LPS has been determined ( Fig. 1) and Neu5Ac occupies the same molecular environment as in isolate 375, that is attached to the β-galactose of lactose attached to the distal heptose (23). In addition, disialylated species have also been detected in the LPS of this isolate (23). To analyse LPS sialylation in a comprehensive manner in these two NTH i isolates, mutant strains in which lic3A (1) and siaB, the CMP-Neu5Ac synthetase gene, had been disrupted were constructed, along with a double lic3Alic3B mutant.
Bacterial lysates prepared from wildtype isolates 375 and 1003 and mutant strains were electrophoresed to visualise LPS profiles. LPS from the wild-type and lic3A and lic3B mutant strains of NTHi 375 and 1003 was then purified and the glycan profiles determined using ESI-MS techniques (8) . The LPS profile of wildtype isolate 1003 exhibits four bands, the upper two bands (bands 1 and 2 indicated on Fig. 2a ) are removed upon neuraminidase treatment, results that are consistent with there being monoand disialylated species (23). In 1003lic3A and 1003lic3B mutant strains only one sialylated band (band 2 in Fig. 2a) is observed, the upper sialylated band evident in wild-type 1003 LPS is absent from the LPS profiles of the mutants. In the 1003lic3Alic3B mutant strain all sialylated glycoforms are absent. Structural analysis of the LPS of 1003lic3B revealed that glycoforms containing only a single Neu5Ac residue are present in this strain, whereas, analysis of 1003lic3A derived LPS identified disialylated species (Table 1A) . The absence of the upper sialylated band in the LPS profile of strain 1003lic3A may be due to decreased levels of disialylation in this mutant strain compared to wildtype.
Wild-type isolate 375 displays a LPS electrophoretic profile comprising three distinguishable bands, the upper of which is a minor band that shifts in molecular weight following neuraminidase treatment (Fig. 2b) . This minor upper band is believed to represent the highest molecular weight disialylated LPS species present in this bacterium. The major middle band remains, whilst a more intense lower band appears in neuraminidase treated LPS. Isolated 375 possesses monosialylated LPS species and a minor proportion of disialylated species (2) . In the 375lic3B mutant, the minor upper band observed with wild-type LPS was not present indicating the likely absence of disialylated species in this mutant. However, a sialylation phenotype was evident upon neuraminidase treatment, this shift in the mobility of the LPS suggests that monosialylated species are present in this mutant strain. In the 375lic3A mutant, LPS sialylation is significantly higher than that observed in wildtype. Neuraminidase treatment of this hypersialylated LPS resulted in the loss of the intense upper bands. The profile of neuraminidase treated 375lic3A LPS is altered from that of neuraminidase treated 375 wild-type LPS, this result was unexpected and cannot be simply explained. No sialylation phenotype was observed on neuraminidase treatment of the LPS in the 375lic3Alic3B (Fig. 2b) or 375siaB mutant strains (data not shown). Similar to our findings with NTHi 1003, mass spectrometric analysis of the LPS of 375lic3B revealed that glycoforms containing only a single Neu5Ac residue are present in this strain, whereas, analysis of 375lic3A LPS identified disialylated species (Table 1B) . In addition, data from MS/MS analysis of 375lic3A LPS showed clear proof of the disialic acid glycoform consistent with Neu5Ac being directly linked to Neu5Ac in the LPS molecule (data not shown). Measurement of sialyltransferase activity of Lic3B -Lic3A and Lic3B from NTHi isolate 375 were expressed in E. coli fused with the maltosebinding protein and purified on amylose resin. In both cases, the construct was made without the 5'CAAT repeats in order to minimise the effect of phase variation in the recombinant constructs. The 5'CAAT repeats encode corresponding SINQ repeats in the amino acid sequence and their deletion resulted in the truncation of 32 and 35 residues at the N-termini of Lic3A and Lic3B, respectively. We assayed the sialyltransferase activity of purified recombinant Lic3A and Lic3B with fluorescent model compounds ( Table 2 ). Both Lic3A and Lic3B transfer sialic acid to lactose (Lac)-FCHASE (Galβ-1,4-Glc-FCHASE) while only Lic3B transfers to sialyllactose-FCHASE (NeuAcα-2,3-Lac-FCHASE). These profiles of activities suggest that Lic3A can transfer sialic acid only to terminal galactose residues while Lic3B can transfer sialic acid either to a terminal galactose residue or to a terminal Neu5Ac residue. We have shown that Lic3B can form disialic acid on a terminal galactose residue by adding sequentially two Neu5Ac residues using CMPNeu5Ac as donor. After a 120 min incubation time, we observed a distribution of 24.2% Lac-FCHASE, 65% Neu5Acα-2,3-Lac-FCHASE and 10.8 % Neu5Acα-2,8-Neu5Acα-2,3-Lac-FCHASE (Supplementary data). Adding more enzyme or donor did not significantly increase the yield of sialylated products which suggested that the reaction reached an equilibrium between the acceptor and the sialylated products. While assaying Lic3A activity with siallylactose-FCHASE as acceptor, a significant production of Lac-FCHASE rather than the transfer of a second sialic acid was observed. This "sialidase" activity is 4.6-fold higher when it is assayed in the presence of CMP. Thus, Lic3A has significant transialidase activity and performs the "backward" reaction in the presence of sialyllactose and CMP. It is likely that there is a small amount of CMP in the CMP-Neu5Ac used as donor and this explains why we observed degradation of sialyllactose when we assayed Lic3A for α-2,8-sialyltransferase activity. This transialidase activity is much less significant in the case of Lic3B ( Table 2) . Transfer of lic3B into a lic3B-deficient strain background confers increased sialylation -To further analyse the function of Lic3B, the lic3B gene was transferred into a lic3B-deficient strain background, strain Rd, to determine whether a sialylation phenotype specific to lic3B would be acquired. An antibiotic resistance cassette was first introduced into bipA (HI0864), the gene upstream of lic3B, to act as a selectable marker following transformation. The electrophoretic profiles of 1003bipA mutants were examined to confirm that inactivation of b i p A had no detectable effect on the LPS profiles when compared to wild type (data not shown). Transformants containing the lic3B allele in strain Rd exhibited increased LPS sialylation (Fig. 2c ) when compared to the parent strain. Three bands are detectable in the LPS profile of wild-type strain Rd, the middle one of which is sialylated, as illustrated by the fact that treatment with neuraminidase decreases the intensity of this band. The decrease in intensity of this band rather than complete removal on treatment with neuraminidase likely indicates that a nonsialylated band co-migrates with the sialylated LPS glycoform in this strain background. In the RdbipA -lic3B + mutants, the upper of the three bands is also sialylated, with a decrease in intensity of these two upper bands being observed upon neuraminidase treatment. To clarify this observation, strain RdlgtC, containing a mutation in the gene encoding the α-1,4-galactosyltransferase, lgtC, was used as this precludes any competition for the lactose acceptor and the formation of non-sialylated extensions. This has been shown to increase the proportion of observed sialylated glycoforms (1) . Two bands representing sialylated glycoforms are evident in the RdbipA -lgtC -lic3B + mutants that are both removed upon neuraminidase treatment (Fig. 2c) . These findings are consistent with our prediction that the introduction of lic3B into strain Rd increases the degree and complexity of LPS sialylation in that strain.
Mass spectrometric analysis of LPS isolated from strain RdbipA -lgtC -lic3B + showed clear evidence of glycoforms containing 1 and 2 sialic acid residues (Table 3) . These glycoforms were present in relatively equal abundance. Only glycoforms displaying a single Neu5Ac residue were apparent upon analysis of LPS isolated from strain RdlgtC (Table 3) . Serum resistance of sialyltransferase-deficient strains -Neu5Ac is known to influence the resistance of organisms to the killing effect of human sera (2) . The set of sialyltransferase mutants in NTHi isolate 1003 were subject to bactericidal assays to analyse the effect of inactivation of single and combinations of putative sialyltransferase genes upon biological activity of the LPS. The wild-type strain along with the siaB mutant was included in these assays for comparison and assays were repeated multiple times. For NTHi isolate 1003, the wild type strain was most resistant, and the siaB mutant least resistant (>2 log drop), to the killing effect of human sera (Fig. 3) . The 1003lic3Alic3B double mutant was sensitive to serum similar to 1003siaB. Lic3 single mutants displayed intermediate resistance phenotypes. A Student's t test showed a significant difference (P= 0.000336) between strains lacking sialic acid in their LPS (1003lic3Alic3B and 1003siaB) compared to strains possessing 1 or 2 sialic acid residues in their LPS (wildtype 1003, 1003lic3A, 1003lic3B). The difference in serum resistance was not statistically significant between the lic3A and lic3B mutant strains. However, a significant difference (P= 0.05) was shown between wildtype 1003 and the single lic3A and lic3B mutants indicating that disruption of either one of these sialyltranferase genes reduces serum resistance significantly. The results obtained in the serum resistance assay correlated well with the LPS phenotypes described by the MS data. The most heavily sialylated strains corresponded to the most serum resistant phenotypes and the strains unable to sialylate LPS corresponded to the most serum sensitive phenotypes.
DISCUSSION
Sialic acid has been implicated as a virulence factor in several bacterial species. The mechanism by which sialylation of LPS contributes to both the commensal and pathogenic behaviour of NTHi might be key to understanding the pathogenesis of disease caused by this organism. Sialylation of LPS is a critical virulence factor in vivo being required for NTHi to cause otitis media in a chinchilla model of infection (3). H. influenzae lacks the genes required for de novo synthesis of Neu5Ac and must therefore access an external source of the sugar as either a substrate for growth (24) or for modification of LPS via a number of specific sialyltransferases. Sialyltransferases determine the frequency and pattern of LPS sialylation across NTHi strains.
In this study we investigated the function of the sialyltransferase Lic3B, encoded by a gene identified as a close homologue of l i c 3 A . L i c 3 A encodes the only previous biochemically characterised α -2 , 3 -sialyltransferase required for sialylation of lactose in H. influenzae LPS (2). Lic3B and Lic3A are closely related enzymes that have overlapping functions. Evidence presented here from biochemical, structural and mutational analyses supports the role of Lic3B as a bifunctional enzyme with α-2,3-and α-2,8-sialyltransferase activity able to utilise both terminal galactose of lactose and Neu5Ac of sialyllactose as acceptor molecules. The recombinant purified Lic3A protein showed no activity on sialyllactose (1) . Mass spectrometric analysis of LPS isolated from lic3A and lic3B mutant strains of NTHi demonstrated that upon inactivation of lic3B only monosialylated species were detectable whereas following inactivation of lic3A, disialylated species were detected. Furthermore, the introduction of lic3B into a lic3B-deficient strain background revealed a significant increase in LPS sialylation. The presence of disialylated species was confirmed in this modified strain.
Bifunctional sialyltransferase enzymes have previously been described in other mucosal pathogens including C. j e j u n i and N. meningitidis (13, 25) . In C. jejuni, the cstI gene encodes an α-2,3-sialyltransferase and the cstII gene encodes either a monofunctional α-2,3-sialyltransferase or a bifunctional enzyme with α -2,3-and α -2,8-sialyltransferase activity, depending on the allele of Cst-II (13) . Interestingly, Lic3A and Lic3B of H. influenzae and Cst-I and Cst-II of C. jejuni are classified in the same family of carbohydrate-active enzymes as defined by the CAZy classification system (http://afmb.cnrs-mrs.fr/CAZY), indicating the relatedness of these enzymes. In N. meningitidis, the lst gene encodes an enzyme with α-2,3-sialyltransferase activity in strain MC58 (L3 immunotype) and a bifunctional enzyme with α-2,3-and α-2,6-sialyltransferase activity in strain 1 2 6 E ( L 1 immunotype) (25).
T h e monofunctional enzyme from MC58 can be changed into a bifunctional 126E-like enzyme by site-directed mutagenesis of a single amino acid (25). Work is ongoing to determine the specific amino acids that confer bifunctionality of the Lic3B sialyltransferase enzyme.
A strong correlation exists between the epitopes of H. influenzae LPS that are known to have specific biological function and synthesis dependent upon phase variable gene expression. Lic3A and likely Lic3B are both expressed in a phase variable manner. Indeed, all enzymes competing to use the terminal lactose off the distal heptose as an acceptor are phase variably expressed, as is Lic2A which adds the terminal β-galactose of the lactose itself. This makes the sialyllactose, or the alternative digalactoside synthesized when LgtC is dominant, potentially one of the most highly variable LPS epitopes expressed by NTHi. This likely indicates an advantage to the organism in expressing Neu5Ac or alternatively a digalactoside in its LPS under certain conditions. These variable conditions may correspond to changing microenvironments in different host compartments or between hosts. No information is available on the level of expression of the lic3A and lic3B genes but an added level of complexity may be inferred by the fact that both genes have two potential initiation codons. In other phase variable genes it has been shown that different reading frames can relate to differing levels of expression of the gene product (26, 27) . There may therefore be modulation of LPS sialylation phenotypes depending on the relative expression levels of both of these genes.
The lic3A gene is present in all strains tested whilst l i c 3 B is present in only a proportion. It is not clear whether lic3B arose by horizontal transfer or by duplication within the genome. Due to the proximity of lic3B to the hmg locus, it is possible that these isolates belong to the same lineage where some complex ancestral insertion/deletion event has occurred. Due to the lack of redundancy generally associated with pathogenic organisms containing small genomes, it is unlikely that two alleles carrying out identical functions would be maintained within the genome. It has been demonstrated in other organisms that minor sequence changes can confer bifunctionality of sialyltransferase genes (25). It would therefore be reasonable to hypothesise that following gene duplication, minor sequence changes would have been sufficient to confer distinct functional specificities of the Lic3A and Lic3B proteins, favouring the maintenance of the corresponding genes within the genome.
Two other putative sialyltransferases SiaA and LsgB can also be present in NTHi isolates but neither 375 nor 1003 contain the siaA gene. The lsgB gene was mutated, both singly and in combination with the lic3A and lic3B sialyltransferase genes. No effect on sialylation was observed when lsgB was mutated in our NTHi isolate backgrounds, confirming that Lic3A and Lic3B alone are responsible for sialylation of sialyllactose. SiaA and LsgB proteins may be involved in sialylation of the high molecular weight glycoform expressed by some NTHi isolates (12) .
The findings from our study indicate that details of the pathway and mechanism of LPS sialylation in NTHi isolate 375 is somewhat more complex than other isolates studied. The un-expected observation of a hypersialylated phenotype in the 375lic3A mutant could possibly be explained by the transialidase activity of Lic3A under in vitro conditions. In addition to this unexpected hypersialylated phenoype, inactivation of putative sialyltransferase genes within this strain resulted in some unexpected and variable alterations in the LPS profiles between individual transformants that were seemingly not directly related to sialylation. A degree of complexity in the sialylation phenotype of mutant strains was also reported by Jones and coworkers (9) upon investigation of the putative sialyltransferases, SiaA and LsgB, in strain A2. It could be hypothesised that the changes observed in LPS phenotype between individual transformants in NTHi 375 were due to concomitant phase variation events in other LPS biosynthetic genes, perhaps enhanced by an elevated switching rate of gene expression. A further possibility is that changes in the expression of sialyltransferase enzymes could be exerted through some form of transcriptional control of the relevant gene(s).
In this study, a strong correlation was found between incorporation of Neu5Ac on LPS and serum resistance of NTHi, as observed previously (2) . It could be envisaged that Neu5Ac would afford protection from human serum in an analogous way to a capsule potentially explaining the extra investment by NTHi in the presentation of Neu5Ac on their cell surface. This is apparent by the higher percentage of NTHi strains possessing the sialyltransferase gene, lic3B, compared to capsular strains of H. influenzae, and the fact that 25/25 NTHi isolates studied contained Neu5Ac in their LPS (7) . The mechanism by which sialic acid contributes to serum resistance remains to be elucidated. Other potential roles of LPS sialylation may be in modulating antigenic mimicry of LPS epitopes or by modulating host interactions either by an indirect charge effect or by steric hindrance. Sialylation of LPS produces a negative charge on the bacterial surface potentially aiding evasion from phagocytic cells in the host environment. It has been proposed that NTHi forms a biofilm in vivo, associated with increased sialylated LPS glycoforms compared to in vitro grown organisms (5, (28) (29) (30) . Although there has been no formal evidence of an extracellular polysaccharide matrix, one of the cardinal features of a biofilm, the sialylated LPS glycoforms of organisms in vivo are clearly implicated in pathogenesis based on studies in a chinchilla model of otitis media (3, 6) .
The functional significance of expression of a sialylated LPS phenotype in NTHi isolates may be dependent on the 'total package' of LPS glycoforms expressed at any given time in any particular isolate, in addition to the contribution of other surface components. Since there are more complex patterns of LPS glycoforms expressed by NTHi than by almost any other mucosal pathogen that has been analysed, it seems plausible that this complexity might be a key factor in the adaptability of these bacteria between compartments within, and between, hosts.
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Månsson, M., Hood, D.W., Li, J., Richards, J.C., Moxon, E.R. a The α -2,3-sialyltransferase activity was assayed using CMP-Neu5Ac as donor and Galβ-1,4-Glc-FCHASE as acceptor. The sialic acid (Neu5Ac) residue is transferred to the Gal residue (in bold).
b The α-2,8-sialyltransferase activity was assayed using CMP-Neu5Ac as donor and Neu5Acα-2-3-Galβ-1,4-Glc-FCHASE as acceptor. The sialic acid (Neu5Ac) residue is transferred to the Neu5Ac residue (in bold).
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